US-based digital therapeutics company Propeller Health has raised $20m in its series D round led by drug delivery company Aptar Pharma.

Hikma Ventures, 3M Ventures and SR One, respective corporate venturing units of pharmaceutical firm Hikma, manufacturing company 3M and healthcare group GlaxoSmithKline, also took part in the round, as did Safeguard Scientifics and Social Capital.

Founded in 2010, Propeller Health is working on a digital therapy platform for patients suffering from chronic respiratory diseases such as asthma and chronic obstructive…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?